Discuss this with your provider. For diabetes patients, the results are pretty phenomenal. Here is published research article showing in their own words what trial participants said about their time and results from being on Mounjaro. Overwhelming majority said they would recommend the drug.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095514/
Exit Interviews Examining the Patient Experience in Clinical Trials of Tirzepatide for Treatment of Type 2 Diabetes
May 2022, Springer Open Choice, Patient.